Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Occurrences in Normal Human Sera of ‘Incomplete’ Forms of ‘Cold’ Auto–Antibodies

Abstract

THE existence of ‘incomplete’ forms of antibodies active against human erythrocytes and detectable by means of the Coombs test1 is now widely recognized. Rh antibodies are commonly present in this form, and so are some at least of the recently recognized rarer immune antibodies2, such as anti-Kell and anti-S. The fact that the iso-antibodies anti-A and anti-B may similarly exist in incomplete forms is also being increasingly realized3.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Coombs, R. R. A., Mourant, A. E., and Race, R. R., Brit. J. Exp. Path., 26, 255 (1945).

    CAS  PubMed  Google Scholar 

  2. Leading article, Lancet, July 16, 1949.

  3. Witebsky, E., Blood, special issue No. 2, 66 (1948).

  4. Levine, P., and Wigod, M., first meeting of the International Society of Hematology, Buffalo (1948).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DACIE, J. Occurrences in Normal Human Sera of ‘Incomplete’ Forms of ‘Cold’ Auto–Antibodies. Nature 166, 36 (1950). https://doi.org/10.1038/166036a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/166036a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing